Off-label use of erythropoietin may be harmful, doctors are told
AUTOR(ES)
Spurgeon, David
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1976521Documentos Relacionados
- Prescrições off-label em pé diabético
- Indian Medical Association wants off-label prescribing
- Off-label indications for atypical antipsychotics: A systematic review
- Uso off-label de stent farmacológico: eficácia versus efetividade
- Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital